TY  - JOUR

T1  - 160 Antitumor therapy with VEGF receptor tyrosine kinase inhibitor ZD6474 in a mouse model of intestinal cancer

JO  - European Journal of Cancer Supplements

UR  - https://doi.org/10.1016/s1359-6349(04)80168-x

PY  - 2004/09/01

AU  - Goodlad RA

AU  - Ryan A

AU  - Watson J

AU  - Wedge SR

AU  - Pyrah IT

AU  - Mandir N

AU  - Wilkinson RW

ED  - 

DO  - DOI: 10.1016/s1359-6349(04)80168-x

PB  - Elsevier BV

VL  - 2

IS  - 8

SP  - 51

EP  - 51

Y2  - 2026/06/23

ER  -